Both in Pharmaceuticals
Dianthus Therapeutics vs Cogent Biosciences
Over the past year DNTH returned +158.5% and COGT returned +122.9%; their daily moves had a correlation of 0.19.
DNTH +158.5% COGT +122.9%Growth of $1, one year, split-adjusted
| Metric | DNTH | COGT |
|---|---|---|
| Price | $85.81 | $31.49 |
| Market cap | $4.80B | $5.46B |
| Today | +3.76% | +1.38% |
| 1 month | +0.5% | +3.7% |
| 6 months | −5.1% | −12.2% |
| Year to date | +108.2% | −11.3% |
| 1 year | +152.2% | +103.2% |
| Revenue growth (YoY) | +294.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −6598.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 2,520.9× | — |
| Net cash | $886.8M | $568.8M |
| Dividend yield | — | — |
| Volatility (60d) | 38.9% | 39.1% |
| Short % of float | 18.4% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).